Concepedia

Effects of the Selective Progesterone Receptor Modulator Asoprisnil on Uterine Artery Blood Flow, Ovarian Activity, and Clinical Symptoms in Patients with Uterine Leiomyomata Scheduled for Hysterectomy

Julia Wilkens, Kristof Chwalisż, Cong Han, Jane Walker, Susan Ingamells, Alexandra Lawrence, Mary Ann Lumsden, Dharani K. Hapangama, Alistair Williams, Hilary Critchley

The Journal of Clinical Endocrinology & Metabolism · 2008 · 101 citations · 24 references

DOI

Abstract

Asoprisnil moderately reduced uterine artery blood flow. This effect may contribute in part to the clinical effects of asoprisnil.

References

24

The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata

James B. Spies · Obstetrics and Gynecology · 2002 · 632 citations

Uterine-Artery Embolization versus Surgery for Symptomatic Uterine Fibroids

New England Journal of Medicine · 2007 · 398 citations

Hysterectomy surveillance--United States, 1980-1993.

Lisa A. Lepine, Susan D. Hillis, Polly A. Marchbanks et al. · PubMed · 1997 · 314 citations

An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.

Bruce R. Carr, Paul B. Marshburn, Paul T. Weatherall et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 176 citations

, , +17

Determination of total menstrual blood loss

Katrina Wyatt, Paul W. Dimmock, TRACY J. WALKER et al. · Fertility and Sterility · 2001 · 173 citations

, , +9